HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone-Reference-Cited by-同舟云学术

HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone

Published:2016-10-28 Issue:1 Volume:77 Page:74-85
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Day Kathleen C.,Hiles Guadalupe Lorenzatti,Kozminsky Molly,Dawsey Scott J.,Paul Alyssa,Broses Luke J.,Shah Rajal,Kunja Lakshmi P.,Hall Christopher,Palanisamy Nallasivam,Daignault-Newton Stephanie,El-Sawy Layla,Wilson Steven James,Chou Andrew,Ignatoski Kathleen Woods,Keller Evan,Thomas Dafydd,Nagrath Sunitha,Morgan Todd,Day Mark L.

Funder

Department of Defense

NIH

Michigan Institute for Clinical and Health Research

SPORE

NSF

Department of Defense Physician Research Training

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics;Neoplasia;2024-11

2. Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment;Bioorganic Chemistry;2024-10

3. Uncovering the regulatory roles of miR-4319 in tumour progression;Human Gene;2024-09

4. The reactive stroma response regulates the immune landscape in prostate cancer;Journal of Translational Genetics and Genomics;2024-07-24

5. Feasibility study of ADCs targeting TROP-2, HER2, and CD46 in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate;World Journal of Urology;2024-07-11